Cargando…
Oncolytic Adenoviruses: The Cold War against Cancer Finally Turns Hot
SIMPLE SUMMARY: Immunotherapy has revolutionized cancer treatment, as demonstrated by the tremendous success of checkpoint inhibitors in different tumor types. Unfortunately, most patients, particularly patients with non-responsive “cold” tumors, do not benefit from checkpoint inhibitors. Enter “arm...
Autores principales: | Oronsky, Bryan, Gastman, Brian, Conley, Anthony P., Reid, Christopher, Caroen, Scott, Reid, Tony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562194/ https://www.ncbi.nlm.nih.gov/pubmed/36230621 http://dx.doi.org/10.3390/cancers14194701 |
Ejemplares similares
-
Going viral: a review of replication-selective oncolytic adenoviruses
por: Larson, Christopher, et al.
Publicado: (2015) -
The War on Cancer: A Military Perspective
por: Oronsky, Bryan, et al.
Publicado: (2015) -
What Exactly Is Inflammation (and What Is It Not?) †
por: Oronsky, Bryan, et al.
Publicado: (2022) -
Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply
por: Oronsky, Bryan, et al.
Publicado: (2022) -
Superficial Venous-Associated Inflammation from Direct IV Administration of RRx-001 in Rats
por: Caroen, Scott, et al.
Publicado: (2022)